F. Bertolini

Type de document

Co-auteur

G. Talarico

S. Orecchioni

D.N. Vo

M. Villalba

J.M. Valdivielso

K. Todoerti

D. Soncini

V. Retali

M. Passalacqua

A. Neri

A. Nencioni

A. Nahimana

P. Minetto

M. Miglino

I.C. Lopez-Mejia

R.M. Lemoli

C.H. Lecellier

AUH Khan

I. Jariel

J Hernández

F. Guolo

C. Gondeau

M. Gobbi

D. Gitenay

S. Gerbal-Chaloin

L. Fajas

M. Duchosal

M. Daujat

N. Colombo

M. Clavio

M. Cea

E. Carminati

A. Cagnetta

S. Bruzzone

M. Bozic

M. Bergamaschi

S. Belkahla

F. Bejjani

N. Allende-Vega

Date

Source

Serveur académique Lausannois (2)

Mot-clé

ligne (2) Mice (2) Animals (2) puits (1) stress (1) spectacle (1) protéine (1) lipide (1) plomb (1) santé humaine (1) évaluation (1) effet (1) ADN (1) maladie cardiovasculaire (1) abords (agglomération) (1) Treatment (1) Inhibitors (1) Animal models (1) Drama (1) Drug development (1) Immunophenotyping (1) Acute myeloid leukemia (1) DNA damage (1) Acetylation (1) Usage (1) Triglycerides (1) Transcription (1) Protein kinases (1) Protein binding (1) Prognosis (1)

Documents écrit par F. Bertolini (2) | parle de F. Bertolini (1)

Depletion of SIRT6 enzymatic activity increases acute myeloid leukemia cells' vulnerability to DNA-damaging agents.

A. Cagnetta et al.

The PDK1 Inhibitor Dichloroacetate Controls Cholesterol Homeostasis Through the ERK5/MEF2 Pathway.

AUH Khan et al. (6 sept. 2017)